Aurobindo Pharma Approves Buyback of Up to 0.93% Shares at INR 1,475 Each

Aurobindo Pharma Limited's Board has approved a buyback of up to 54,23,728 equity shares, each with a face value of INR 1, at a price of INR 1,475 per share. This represents up to 0.93% of the total number of equity shares in the company's paid-up equity share capital. The total buyback size is INR 800,00,00,000. The buyback is proposed to be made from all equity shareholders through the 'tender offer' route, in accordance with the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018. The record date for the purpose of determining the entitlement and the names of equity shareholders who would be eligible to participate in the buyback is April 17, 2026.